Abilify Related Clinical Trials
Aripiprazole and Topiramate on Free-Choice Alcohol Use [Recruiting]
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia [Completed]
Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs AbilifyŽ 10 mg Tablet in Healthy Volunteers [Not yet recruiting]
Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children [Completed]
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Completed]
Abilify as an Adjunctive Treatment for Refractory Depression [Completed]
A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot [Completed]
Aripiprazole (AbilifyŽ) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder [Recruiting]
Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome [Completed]
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy [Completed]
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression [Completed]
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals [Completed]
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania [Completed]
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Completed]
Oral Aripiprazole Open-Label Rollover Study [Completed]
Trial of Aripiprazole in Trichotillomania [Completed]
Aripiprazole in Adolescents With Schizophrenia [Completed]
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol [Not yet recruiting]
The New Strategy for Pharmacological Treatment in People With Schizophrenia [Recruiting]
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia [Completed]
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia [Recruiting]
Study to Evaluate the Efficacy and Safety of Aripiprazole [Recruiting]
Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics [Completed]
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole [Terminated]
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents [Terminated]
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder [Terminated]
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Completed]
Aripiprazole in Children With Autism: A Pilot Study [Completed]
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia [Completed]
Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects [Completed]
Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD) [Completed]
Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder [Active, not recruiting]
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole [Completed]
Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder [Completed]
Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder [Completed]
Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents [Completed]
Study of Aripiprazole to Treat Children and Adolescents With Autism [Completed]
Aripiprazole in Late Life Bipolar Disorder [Completed]
Neuroimaging Of Treatment Effects in Treatment-Resistant Depression [Recruiting]
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. [Completed]
Aripiprazole Augmentation Therapy in Treatment-resistant Depression [Recruiting]
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine [Completed]
Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI [Recruiting]
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia [Completed]
Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness [Completed]
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. [Completed]
Aripiprazole and Prolactin Study [Completed]
Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning [Completed]
Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Completed]
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Completed]
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) [Completed]
Aripiprazole and Effexor XR Drug Interaction Study [Completed]
Aripiprazole and Lexapro Drug Interaction Study [Completed]
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole [Completed]
Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial [Withdrawn]
Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression [Completed]
Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) [Recruiting]
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials [Completed]
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) [Terminated]
FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders [Completed]
A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia [Completed]
Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia [Recruiting]
Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia [Completed]
Aripiprazole Effects on Alcohol Drinking and Craving [Recruiting]
European Long-acting Antipsychotics in Schizophrenia Trial [Recruiting]
Aripiprazole and Resistant Postpartum Depression [Recruiting]
Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia [Terminated]
ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness [Completed]
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism [Recruiting]
Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI [Recruiting]
Aripiprazole in Children and Adolescents With Bipolar I Disorder [Completed]
Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness [Completed]
Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder [Completed]
Aripiprazole Oral Acceptability Trial [Completed]
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia [Recruiting]
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia [Completed]
Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome [Terminated]
A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder [Completed]
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders [Completed]
Aripiprazole in Fragile X Syndrome [Completed]
Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia [Recruiting]
Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia [Completed]
Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis [Active, not recruiting]
Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression [Completed]
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) [Terminated]
Trial of Aripiprazole in the Treatment of CD in Adolescents [Completed]
Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism- [Completed]
Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects [Completed]
A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode [Completed]
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia [Completed]
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study [Terminated]
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) [Completed]
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder [Completed]
Fluoxetine vs Aripiprazole Comparative Trial (FACT) [Recruiting]
Aripiprazole Once-monthly in Patients With Schizophrenia [Completed]
A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients [Completed]
|